Secondary prevention program:: Impact on cardiovascular risk

被引:1
|
作者
Plaza, Ignacio [1 ]
Garcia, Sara [1 ]
Madero, Rosario [1 ]
Zapata, Maria A. [1 ]
Perea, Jesus [1 ]
Sobrino, Jose A. [1 ]
Lopez-Sendon, Jose L. [1 ]
机构
[1] Hosp La Paz, Unidad Lipidos, Serv Cardiol, Madrid 28046, Spain
来源
REVISTA ESPANOLA DE CARDIOLOGIA | 2007年 / 60卷 / 02期
关键词
secondary prevention program; coronary heart disease; cardiovascular risk factors;
D O I
10.1157/13099469
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aims of this study were to determine the effect of a secondary prevention program on the treatment and control of coronary risk factors and to assess whether it improves functional capacity. The study involved 401 patients with coronary heart disease (mean age 57.1 years; 89% men). Clinical and anthropometric data, including blood pressure, were recorded, and electrocardiography, laboratory analysis and exercise testing were performed before and after the program, which lasted 2-3 months. The therapeutic intervention comprised pharmacological treatment of coronary risk factors and the encouragement of life-style changes, including a recommended medically supervised physical exercise regime. By the end of the program, lipid and lipoprotein levels had improved significantly (P < 001 for all). The proportion of smokers decreased from 37.4% to 3.6% (P < 001). Functional capacity increased by 26% (P <.001). In conclusion, patients who took part in the secondary prevention program experienced improvements in cardiovascular risk profile and functional capacity.
引用
下载
收藏
页码:205 / 208
页数:4
相关论文
共 50 条
  • [21] Is the control of cardiovascular risk factors in secondary prevention adequate?
    Alejandra Oringa, M.
    Canivell Fuste, Silvia
    La Fuente Van Der Sluis, Sarah
    Ortiz Molina, Jacinto
    ATENCION PRIMARIA, 2009, 41 (01): : 56 - 57
  • [22] Thienopyridine therapy and risk for cardiovascular events in secondary prevention
    Peter P. Toth
    Annemarie Armani
    Current Atherosclerosis Reports, 2009, 11 : 364 - 370
  • [23] Thienopyridine therapy and risk for cardiovascular events in secondary prevention
    Toth, Peter P.
    Armani, Annemarie
    CURRENT ATHEROSCLEROSIS REPORTS, 2009, 11 (05) : 364 - 370
  • [24] Risk factors associated with secondary prevention of cardiovascular diseases
    Chinaia, Cleo
    Juliano, Yara
    Armond, Jane de Eston
    Souza, Patricia Colombo
    MUNDO DA SAUDE, 2018, 42 (04): : 958 - 965
  • [25] Cardiovascular disease risk factor status of patients referred to a private practice stroke secondary prevention program
    Lafranchise, EF
    Widener, WG
    Mitchell, BS
    Salmon, RD
    Blaschko, E
    Levinrad, LI
    Gordon, NF
    ANNALS OF NEUROLOGY, 1999, 46 (03) : 504 - 504
  • [26] Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program
    Ratner, R
    Goldberg, R
    Haffner, S
    Marcovina, S
    Orchard, T
    Fowler, S
    Temprosa, M
    DIABETES CARE, 2005, 28 (04) : 888 - 894
  • [28] Cardiovascular secondary prevention
    Rupprecht, H. -J.
    CLINICAL RESEARCH IN CARDIOLOGY, 2006, 95 : 1 - 5
  • [29] Impact of education on secondary prevention in patients undergoing cardiovascular surgery
    Kerbage, Soraya
    Burgos, Sebastian
    Diaz, Lidia
    Castaneda, Luis
    Comes, Cecilia
    Angelino, Arnaldo
    Mautner, Branco
    Favaloro, Roberto
    de Urquiza, Ignacio
    CIRCULATION, 2012, 125 (19) : E800 - E800
  • [30] Zooming in on microRNAs for refining cardiovascular risk prediction in secondary prevention
    Santovito, Donato
    Weber, Christian
    EUROPEAN HEART JOURNAL, 2017, 38 (07) : 524 - 528